In a study by Honarvar et al., a HER2 specific peptide A9 with nanomolar affinity was derived from transtuzumab-Fab portion and was used as a 111In radio labeled imaging probe for HER2 positive tumor tissue18. Here, ERBB2 is linked to neoplasm.